tiprankstipranks
Digi International Inc. (DGII)
NASDAQ:DGII
US Market
Want to see DGII full AI Analyst Report?

Digi International (DGII) Earnings Dates, Call Summary & Reports

459 Followers

Earnings Data

Report Date
Aug 12, 2026
After Close (Confirmed)
Period Ending
2026 (Q3)
Consensus EPS Forecast
0.65
Last Year’s EPS
0.53
Same Quarter Last Year
Based on 4 Analysts Ratings

Earnings Call Summary

Q2 2026
Earnings Call Date:May 06, 2026|
% Change Since:
|
Earnings Call Sentiment|Neutral
Mixed results: the quarter was materially impacted by a voluntary product recall that drove revenue and margin headwinds, lower procedure volumes and a significant year-over-year decline in net income and adjusted EBITDA. Offsetting positives include strong dietary supplement growth (+19.1%), expansion of the salesforce to ~120 reps, a 16.5% increase in newly trained practitioners (a leading indicator for future revenue), operational actions to restore supply (second shift at Asteria and third-party support), maintained full-year guidance (revenue >$190M, adjusted EBITDA >$38M), and positive operating cash flow. Management frames the recall as temporary and expects procedure revenue to return to growth in the second half of 2026.
Company Guidance
Management reiterated 2026 guidance of revenue above $190.0 million and adjusted EBITDA greater than $38.0 million, while reporting Q1 revenue down 8.3% to $44.9M (procedure revenue down 13.2% to $31.3M, including an estimated $1.7M recall impact; dietary supplement revenue up 19.1% to $11.0M), gross profit margin of 68.9% (vs. 74.3% year‑ago; ~$1.1M incremental recall cost), adjusted EBITDA of $8.7M (19.4% margin), net income of $2.7M and diluted EPS of $0.06 (vs. $15.8M/$0.37 prior year), cash flow from operations of $3.9M and cash & equivalents of $5.3M as of 3/31/26; Asteria produced ~30% of shipped pellets in Q1 (vs. >50% in Q4’25), management expects to fully restore Asteria supply by end of Q2, expects H1 procedure growth to be moderately lower than prior forecasts but a return to growth in H2, and projects dietary supplement revenue growth at a mid‑ to high‑single‑digit rate for 2026.
Dietary Supplement Revenue Growth
Dietary supplement revenue grew 19.1% year-over-year to $11.0 million in Q1 2026, driven primarily by continued growth of the e-commerce channel. Company expects supplement revenue to grow at a mid- to high single-digit rate for full-year 2026.
Salesforce Expansion and Commercial Investment
Expanded commercial organization with over 25 new sales hires in Q1, taking total sales personnel from just over 90 at the end of 2025 to approximately 120 planned for 2026. Management reports this expansion is substantially complete and intended to drive future practitioner recruitment and revenue growth.
Practitioner Training Pipeline
Trained more than 200 new practitioners in Q1, a 16.5% increase versus Q1 2025. Management notes new practitioner training is a leading indicator for future procedures and supplement sales, with typical contribution beginning about six months after training.
Maintained Full-Year Guidance
Management maintained 2026 guidance: full-year revenue above $190 million and adjusted EBITDA greater than $38 million, asserting confidence in a return to procedure revenue growth in the second half of 2026 despite the Q1 disruption.
Operational Recovery Actions at Asteria Health
Implemented measures to restore supply, including adding a second production shift at Asteria Health and using third-party pharmacy partners to fulfill demand. Asteria produced ~30% of shipped pellets in Q1 vs. >50% in Q4 2025; management expects Asteria supply continuity to be fully restored by the end of Q2 2026.
Positive Cash Flow and Liability Reduction
Generated operating cash flow of $3.9 million in Q1 2026 and held $5.3 million in cash and cash equivalents as of March 31, 2026. Company fully repaid remaining share repurchase liabilities in January 2026.

Digi International (DGII) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

DGII Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 12, 2026
2026 (Q3)
0.65 / -
0.53
May 06, 2026
2026 (Q2)
0.58 / 0.62
0.5121.57% (+0.11)
Feb 04, 2026
2026 (Q1)
0.55 / 0.56
0.512.00% (+0.06)
Nov 12, 2025
2025 (Q4)
0.51 / 0.56
0.527.69% (+0.04)
Aug 06, 2025
2025 (Q3)
0.49 / 0.53
0.56.00% (+0.03)
May 07, 2025
2025 (Q2)
0.47 / 0.51
0.494.08% (+0.02)
Feb 05, 2025
2025 (Q1)
0.48 / 0.50
0.484.17% (+0.02)
Nov 13, 2024
2024 (Q4)
0.47 / 0.52
0.520.00% (0.00)
Aug 07, 2024
2024 (Q3)
0.49 / 0.50
0.50.00% (0.00)
May 01, 2024
2024 (Q2)
0.47 / 0.49
0.5-2.00% (-0.01)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

DGII Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 06, 2026
$58.85$62.03+5.40%
Feb 04, 2026
$46.55$44.72-3.93%
Nov 12, 2025
$35.97$38.53+7.12%
Aug 06, 2025
$31.95$32.10+0.47%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Digi International Inc. (DGII) report earnings?
Digi International Inc. (DGII) is schdueled to report earning on Aug 12, 2026, After Close (Confirmed).
    What is Digi International Inc. (DGII) earnings time?
    Digi International Inc. (DGII) earnings time is at Aug 12, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is DGII EPS forecast?
          DGII EPS forecast for the fiscal quarter 2026 (Q3) is 0.65.